{"paper_id": "62a8ff6f0eef73c4d8a3e61e6d1f86465b9fbaab", "metadata": {"title": "Accepted Article COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies", "authors": [{"first": "Mahmoud", "middle": [], "last": "Mahmoud", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Mohanad", "middle": [], "last": "Youssef", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Mohammad", "middle": [], "last": "Hussein", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Abdallah", "middle": ["S"], "last": "Attia", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Rami", "middle": [], "last": "Elshazli", "suffix": "", "affiliation": {"laboratory": "", "institution": "Horus University -Egypt", "location": {"settlement": "New Damietta", "country": "Egypt"}}, "email": ""}, {"first": "Mahmoud", "middle": [], "last": "Omar", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Ghassan", "middle": [], "last": "Zora", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Ashraf", "middle": [], "last": "Farhoud", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Ahmad", "middle": [], "last": "Elnahla", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Areej", "middle": [], "last": "Shihabi", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Eman", "middle": [], "last": "Toraih", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans, Louisiana", "country": "USA"}}, "email": ""}, {"first": "Manal", "middle": [], "last": "Fawzy", "suffix": "", "affiliation": {"laboratory": "", "institution": "Suez Canal University", "location": {"settlement": "Ismailia", "country": "Egypt"}}, "email": ""}, {"first": "Emad", "middle": [], "last": "Kandil", "suffix": "", "affiliation": {"laboratory": "", "institution": "Tulane University", "location": {"settlement": "New Orleans", "region": "LA", "country": "USA"}}, "email": "ekandil@tulane.edu"}, {"first": "", "middle": [], "last": "Kandil", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [], "body_text": [{"text": "Data extraction was conducted by four authors (MY, GZ, AA, and AF). The process included using a two-step approach: firstly, we screened titles and abstracts for eligibility according to the study objective, and secondly, we screened the full-text article of relevant abstracts.", "cite_spans": [], "ref_spans": [], "section": "Data extraction"}, {"text": "The Newcastle-Ottawa Scale was used for assessing the quality of eligible manuscripts. Publication bias was assessed with the Newcastle-Ottawa Quality Assessment Scale cohort studies. 17 ", "cite_spans": [{"start": 184, "end": 186, "text": "17", "ref_id": "BIBREF18"}], "ref_spans": [], "section": "Quality assessment"}, {"text": "The pooled estimates were extracted using RevMan version 5.3. Descriptive summary statistics in the form of mean, standard deviation, and range for continuous parametric measures were tabulated. Pairwise comparison between mild and severe COVID-19 patients was performed. Overall pooled odds ratio (OR) or standardized mean difference (SMD) with 95% confidence intervals (CI) were estimated for categorical Accepted Article and quantitative variables, respectively. A Fixed-effects model was employed unless significant heterogeneity was detected. In this case, the Random-effects model has applied. 18 Heterogeneity was considered significant if the I-square value exceeds 50%, or its p-value was less than 0.1.", "cite_spans": [{"start": 600, "end": 602, "text": "18", "ref_id": null}], "ref_spans": [], "section": "Pairwise comparison and heterogeneity assessment"}, {"text": "Subgroup analyses by the location of the patients, publication date, sample size, and quality score were performed. Sensitivity analysis was carried out by removing one study each time, to reflect its effect size on the overall OR.", "cite_spans": [], "ref_spans": [], "section": "Pairwise comparison and heterogeneity assessment"}, {"text": "Publication bias was assessed via Begg's funnel plot and Egger's linear regression approach using Comprehensive Meta-analysis software. 19 An asymmetric funnelshape or a p-value <0.1 indicated significant bias. 20", "cite_spans": [{"start": 136, "end": 138, "text": "19", "ref_id": null}], "ref_spans": [], "section": "Pairwise comparison and heterogeneity assessment"}, {"text": "Meta-regression analysis was employed using OpenMeta Analyst software, taking into consideration the following study characteristics; sample size, mean age of patients, percentage of males, city of the hospital, publication date, and quality score.", "cite_spans": [], "ref_spans": [], "section": "Meta-regression analysis"}, {"text": "To evaluate the reliability of statistical appraisal of this meta-analysis study, we used TSA software (version 0.9.5.10 beta) by merging several available sample sizes of applicable studies with the threshold of statistical influence to reduce the unintentional miscalculations and improve the strength of anticipations. We used twoside trials and type I error with a calculated power of 5% and 80%. If the cumulative Z-curve crosses the monitoring boundaries, no additional trials would be required. On the contrary, if the Z-curve did not accomplish the boundary levels, the necessary threshold requires additional records to achieve a prominent significance.", "cite_spans": [], "ref_spans": [], "section": "Trial sequential analysis (TSA)"}, {"text": "This article is protected by copyright. All rights reserved.", "cite_spans": [], "ref_spans": [], "section": "Results"}, {"text": "Following the removal of duplicates (n=1,870), our database search identified 2,582 unique citations, of which 186 full-text articles were assessed. A total of 20 eligible retrospective cohort studies, including 3428 positively confirmed COVID-19 patients, were enrolled in the current meta-analysis. The workflow of the process of study selection is demonstrated in Figure 1 . All articles were published during the period between January 30 and April 16, 2020. Most of them were from Wuhan city (13), three from Zhejiang, one from Guangdong, one from Hubei, one from Guangdong, and one from Anhui. As depicted in Table 1 , the sample size of studies ranged from 21 to 651 cohorts. The mean age of patients was 53.8 years, and 57.8% were men. In the included studies, the severe disease was detected in 36.2% of patients and the average survival rate was 72.18%. All studies except for three scored more than five on the scale. Two studies scored a three, and one study scored a two. (Figure S1 ). Apart from ALT data, significant heterogeneity was detected in laboratory results. Subgroup analysis by the origin of the hospital, publication date, sample size, and quality score of the studies failed to resolve the obvious heterogeneity. This article is protected by copyright. All rights reserved. Figure S2 ). Apart of cardiovascular disease, homogeneity between studies was detected.", "cite_spans": [], "ref_spans": [{"start": 367, "end": 375, "text": "Figure 1", "ref_id": "FIGREF2"}, {"start": 615, "end": 622, "text": "Table 1", "ref_id": null}, {"start": 985, "end": 995, "text": "(Figure S1", "ref_id": "FIGREF2"}, {"start": 1301, "end": 1310, "text": "Figure S2", "ref_id": null}], "section": "Characteristics of the included studies"}, {"text": "A total of 17 studies reported treatment to be administered to COVID-19 patients. On comparison between the two groups, severe patients were nearly three times more likely to receive steroids (OR = 3.17, 95%CI = 3.02-4.97, p <0.001) and immunoglobulins (OR = 2.75, 95%CI = 1.09-6.94, p = 0.032). Sensitivity analysis revealed that the studies of Wang 31 and Zhang 24 contributed in the significant heterogeneity observed in treatment results ( Table 2) . Figure S3 ). Considerable heterogeneity was observed for the outcomes.", "cite_spans": [], "ref_spans": [{"start": 444, "end": 452, "text": "Table 2)", "ref_id": "TABREF0"}, {"start": 455, "end": 464, "text": "Figure S3", "ref_id": null}], "section": "Pooled analysis of treatment"}, {"text": "Meta-regression analysis for study characteristics showed higher odds of mortality in articles involving Wuhun hospitals (coefficient = 4.30, 95%CI = 3.07-5.54, p <0.001) (Supporting Information Materials Table S1 ).", "cite_spans": [], "ref_spans": [{"start": 205, "end": 213, "text": "Table S1", "ref_id": null}], "section": "Pooled analysis of COVID-19 outcomes"}, {"text": "The funnel plot of laboratory and clinical parameters is shown in Figure S4 . Egger's test showed no publication bias for all variables (p >0.1) except for two; cardiovascular and cerebrovascular diseases (p = 0.061 and 0.041) ( Table 2) .", "cite_spans": [], "ref_spans": [{"start": 66, "end": 75, "text": "Figure S4", "ref_id": null}, {"start": 229, "end": 237, "text": "Table 2)", "ref_id": "TABREF0"}], "section": "Publication bias"}, {"text": "We applied TSA on mortality rate available among all eligible articles of COVID-19 patients with a mild and severe exhibition and indicated that the cumulative Z-curve transverses the monitoring boundaries before reaching the required sample size and achieving considerable significant and so no further studies are necessary (Figure 2 ).", "cite_spans": [], "ref_spans": [{"start": 326, "end": 335, "text": "(Figure 2", "ref_id": null}], "section": "Trial sequential analysis"}, {"text": "Our meta-analysis including 3428 subjects from 20 retrospective studies explored the potential relationship between liver injury and the severity of COVID-19 disease. We found that liver dysfunction seemed to be higher in patients with severe outcomes from COVID-19 infection.", "cite_spans": [], "ref_spans": [], "section": "Discussion"}, {"text": "Our results were in agreement with a previous study review. 21 Previously, liver injury has been reported as an important risk factor for severe outcome and death in SARS Accepted Article and Middle East Respiratory Syndrome. [22] [23] [24] [25] Patients in our study who had severe presentations of COVID-19 disease had higher levels of AST, ALT, bilirubin, and lower albumin levels. Our results are consistent with recent studies on COVID-19 disease that showed that the incidence of liver injury ranged from 58% to 78%, mainly indicated by elevated AST, ALT, and total bilirubin levels accompanied by slightly decreased albumin levels. 26, 27 In a recent study, Guan et al. documented that higher serum levels of AST were observed in nearly 18% of patients with non-severe COVID-19 disease and approximately 56% of patients with severe COVID-19 infection. 28 Moreover, in that study, higher serum levels of ALT were also observed in nearly 20% of patients with non-severe COVID-19 presentation, and approximately 28% of patients with severe COVID manifestation. 28 Similar findings in Huang et al. were also observed, where patients with severe COVID-19 features had an increased incidence of liver injury.", "cite_spans": [{"start": 60, "end": 62, "text": "21", "ref_id": null}, {"start": 226, "end": 230, "text": "[22]", "ref_id": null}, {"start": 231, "end": 235, "text": "[23]", "ref_id": null}, {"start": 236, "end": 240, "text": "[24]", "ref_id": null}, {"start": 241, "end": 245, "text": "[25]", "ref_id": "BIBREF19"}, {"start": 639, "end": 642, "text": "26,", "ref_id": "BIBREF20"}, {"start": 643, "end": 645, "text": "27", "ref_id": "BIBREF21"}, {"start": 859, "end": 861, "text": "28", "ref_id": "BIBREF22"}, {"start": 1065, "end": 1067, "text": "28", "ref_id": "BIBREF22"}], "ref_spans": [], "section": "Discussion"}, {"text": "Postmortem liver biopsies specimens were observed in deceased COVID-19 patients.", "cite_spans": [], "ref_spans": [], "section": "Discussion"}, {"text": "The findings showed mild lobular and portal activity along with microvascular stenosis, indicating the injury could have been caused by either COVID-19 disease or drug-induced liver injury. 3 Similar to the treatment of SARS, steroids, antivirals, and antibiotics are widely used for the treatment of COVID-19. [29] [30] [31] These drugs are all potential causes of liver injury during COVID-19 treatment but have not yet been evident. 32 A recent study reported that the liver injury observed in COVID-19 patients might be caused by lopinavir, which is used as an antiviral for the treatment of SARS-CoV-2 infection. 33 It is worth noting that the specific underlying causes of liver injury and elevated levels of liver enzymes in COVID-19 patients are still limited. However, collectively the proposed mechanisms might include \"hyperactivated immune This article is protected by copyright. All rights reserved.", "cite_spans": [{"start": 190, "end": 191, "text": "3", "ref_id": "BIBREF3"}, {"start": 311, "end": 315, "text": "[29]", "ref_id": "BIBREF23"}, {"start": 316, "end": 320, "text": "[30]", "ref_id": "BIBREF24"}, {"start": 321, "end": 325, "text": "[31]", "ref_id": "BIBREF25"}, {"start": 436, "end": 438, "text": "32", "ref_id": "BIBREF26"}], "ref_spans": [], "section": "Discussion"}, {"text": "responses and cytokine storm-related systemic inflammation, psychological stress, drug toxicity, and progression of pre-existing liver diseases\" as detailed by Li and Fan. 46 Further studies are needed to investigate the mechanisms of liver dysfunction in COVID-19 disease as a direct outcome of infection and the possible effects that treatment has on the liver.", "cite_spans": [{"start": 160, "end": 166, "text": "Li and", "ref_id": null}, {"start": 172, "end": 174, "text": "46", "ref_id": "BIBREF33"}], "ref_spans": [], "section": "Accepted Article"}, {"text": "Limitations of our study include the following; Firstly, all the studies included in this meta-analysis used a case-control or cohort design, which are susceptible to recall and selection biases. Secondly, we could not distinguish if the liver dysfunction in COVID-19 patients was an acute liver injury or exacerbated chronic liver disease.", "cite_spans": [], "ref_spans": [], "section": "Accepted Article"}, {"text": "Lastly, the enrolled studies focused on Chinese patients, which restricted a more precise estimation of liver dysfunction in the context of other races.", "cite_spans": [], "ref_spans": [], "section": "Accepted Article"}, {"text": "In this meta-analysis, we comprehensively analyzed liver dysfunction in accordance with the severity of clinical outcomes in COVID-19 patients. Liver dysfunction was associated with severe COVID-19 infection. Patients presented with abnormal liver function tests are at higher risk of severe clinical outcomes. Close monitoring of the presence of liver dysfunction may be beneficial as an early indicator of worse outcomes. This may serve to better prepare the treatment of patients.", "cite_spans": [], "ref_spans": [], "section": "Conclusions"}, {"text": "None.", "cite_spans": [], "ref_spans": [], "section": "Funding"}, {"text": "This article is protected by copyright. All rights reserved.", "cite_spans": [], "ref_spans": [], "section": "Funding"}, {"text": "All authors declare no conflict of interest. This article is protected by copyright. All rights reserved. ", "cite_spans": [], "ref_spans": [], "section": "Conflicts of interest"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", "authors": [{"first": "N", "middle": [], "last": "Chen", "suffix": ""}, {"first": "M", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "X", "middle": [], "last": "Dong", "suffix": ""}], "year": 2020, "venue": "Lancet", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/S0140-6736(20)30211-7"]}}, "BIBREF1": {"ref_id": "b1", "title": "Coronavirus disease 2019 (COVID-19)", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Situation Report -84. World Heal Organ", "authors": [], "year": 2020, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1001/jama.2020.2633"]}}, "BIBREF3": {"ref_id": "b3", "title": "Pathological findings of COVID-19 associated with acute respiratory distress syndrome", "authors": [{"first": "Z", "middle": [], "last": "Xu", "suffix": ""}, {"first": "L", "middle": [], "last": "Shi", "suffix": ""}, {"first": "Y", "middle": [], "last": "Wang", "suffix": ""}], "year": 2020, "venue": "Lancet Respir Med", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/S2213-2600(20"]}}, "BIBREF4": {"ref_id": "b4", "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan", "authors": [{"first": "C", "middle": [], "last": "Huang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}], "year": 2020, "venue": "China. Lancet", "volume": "", "issn": "", "pages": "30183--30188", "other_ids": {"DOI": ["10.1016/S0140-6736(20"]}}, "BIBREF5": {"ref_id": "b5", "title": "Coronavirus as a possible cause of severe acute respiratory syndrome", "authors": [{"first": "Jsm", "middle": [], "last": "Peiris", "suffix": ""}, {"first": "S", "middle": ["T"], "last": "Lai", "suffix": ""}, {"first": "Llm", "middle": [], "last": "Poon", "suffix": ""}], "year": 2003, "venue": "Lancet", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/S0140-6736(03)13077-2"]}}, "BIBREF6": {"ref_id": "b6", "title": "A novel coronavirus from patients with pneumonia in China", "authors": [{"first": "N", "middle": [], "last": "Zhu", "suffix": ""}, {"first": "D", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "W", "middle": [], "last": "Wang", "suffix": ""}], "year": 2019, "venue": "N Engl J Med", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1056/NEJMoa2001017"]}}, "BIBREF7": {"ref_id": "b7", "title": "The novel coronavirus 2019 (2019-nCoV) uses the SARScoronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells", "authors": [{"first": "M", "middle": [], "last": "Hoffmann", "suffix": ""}, {"first": "H", "middle": [], "last": "Kleine-Weber", "suffix": ""}, {"first": "N", "middle": [], "last": "Krueger", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Mueller", "suffix": ""}, {"first": "C", "middle": [], "last": "Drosten", "suffix": ""}, {"first": "S", "middle": [], "last": "Poehlmann", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1101/2020.01.31.929042"]}}, "BIBREF8": {"ref_id": "b8", "title": "Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection", "authors": [{"first": "X", "middle": [], "last": "Chai", "suffix": ""}, {"first": "L", "middle": [], "last": "Hu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhang", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1101/2020.02.03.931766"]}}, "BIBREF10": {"ref_id": "b10", "title": "Cholangiocyte pathobiology", "authors": [], "year": 2019, "venue": "Nat Rev Gastroenterol Hepatol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1038/s41575-019-0125-y"]}}, "BIBREF11": {"ref_id": "b11", "title": "Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China", "authors": [{"first": "P", "middle": [], "last": "Mo", "suffix": ""}, {"first": "Y", "middle": [], "last": "Xing", "suffix": ""}, {"first": "Y", "middle": [], "last": "Xiao", "suffix": ""}], "year": 2020, "venue": "Clin Infect Dis", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1093/cid/ciaa270"]}}, "BIBREF12": {"ref_id": "b12", "title": "Diagnostic utility of clinical laboratory data This article is protected by copyright. All rights reserved. Accepted Article determinations for patients with the severe COVID-19", "authors": [{"first": "Y", "middle": [], "last": "Gao", "suffix": ""}, {"first": "T", "middle": [], "last": "Li", "suffix": ""}, {"first": "M", "middle": [], "last": "Han", "suffix": ""}], "year": 2020, "venue": "J Med Virol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1002/jmv.25770"]}}, "BIBREF13": {"ref_id": "b13", "title": "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study", "authors": [{"first": "T", "middle": [], "last": "Chen", "suffix": ""}, {"first": "D", "middle": [], "last": "Wu", "suffix": ""}, {"first": "H", "middle": [], "last": "Chen", "suffix": ""}], "year": 2020, "venue": "BMJ", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1136/bmj.m1091"]}}, "BIBREF14": {"ref_id": "b14", "title": "Clinical and immunologic features in severe and moderate Coronavirus Disease", "authors": [{"first": "G", "middle": [], "last": "Chen", "suffix": ""}, {"first": "D", "middle": [], "last": "Wu", "suffix": ""}, {"first": "W", "middle": [], "last": "Guo", "suffix": ""}], "year": 2019, "venue": "J Clin Invest", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1172/JCI137244"]}}, "BIBREF15": {"ref_id": "b15", "title": "Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease", "authors": [{"first": "C", "middle": [], "last": "Wu", "suffix": ""}, {"first": "X", "middle": [], "last": "Chen", "suffix": ""}, {"first": "Y", "middle": [], "last": "Cai", "suffix": ""}], "year": 2019, "venue": "JAMA Intern Med", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1001/jamainternmed.2020.0994"]}}, "BIBREF16": {"ref_id": "b16", "title": "Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings", "authors": [{"first": "X", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "H", "middle": [], "last": "Cai", "suffix": ""}, {"first": "J", "middle": [], "last": "Hu", "suffix": ""}], "year": 2020, "venue": "Int J Infect Dis", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/j.ijid.2020.03.040"]}}, "BIBREF17": {"ref_id": "b17", "title": "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement", "authors": [{"first": "D", "middle": [], "last": "Moher", "suffix": ""}, {"first": "A", "middle": [], "last": "Liberati", "suffix": ""}, {"first": "J", "middle": [], "last": "Tetzlaff", "suffix": ""}], "year": 2009, "venue": "PLoS Med", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1371/journal.pmed.1000097"]}}, "BIBREF18": {"ref_id": "b18", "title": "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses", "authors": [{"first": "A", "middle": [], "last": "Stang", "suffix": ""}], "year": 2010, "venue": "Eur J Epidemiol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1007/s10654-010-9491"]}}, "BIBREF19": {"ref_id": "b19", "title": "Hematological and biochemical factors predicting SARS fatality in Taiwan", "authors": [{"first": "H", "middle": ["L"], "last": "Chang", "suffix": ""}, {"first": "K", "middle": ["T"], "last": "Chen", "suffix": ""}, {"first": "S", "middle": ["K"], "last": "Lai", "suffix": ""}], "year": 2006, "venue": "J Formos Med Assoc", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/S0929-6646(09)60183-2"]}}, "BIBREF20": {"ref_id": "b20", "title": "Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China. medRxiv", "authors": [{"first": "Y", "middle": [], "last": "Huang", "suffix": ""}, {"first": "H", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "R", "middle": [], "last": "Yang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Xu", "suffix": ""}, {"first": "X", "middle": [], "last": "Feng", "suffix": ""}, {"first": "P", "middle": [], "last": "Gong", "suffix": ""}], "year": 2020, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1101/2020.02.27.20029009"]}}, "BIBREF21": {"ref_id": "b21", "title": "Clinical characteristics of 82 death cases with COVID-19", "authors": [{"first": "B", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "X", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "Y", "middle": [], "last": "Qiu", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1101/2020.02.26.20028191"]}}, "BIBREF22": {"ref_id": "b22", "title": "Clinical Characteristics of Coronavirus Disease 2019 in China", "authors": [{"first": "W", "middle": ["J"], "last": "Guan", "suffix": ""}, {"first": "Z", "middle": ["Y"], "last": "Ni", "suffix": ""}, {"first": "Y", "middle": [], "last": "Hu", "suffix": ""}], "year": 2020, "venue": "N Engl J Med", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1056/NEJMoa2002032"]}}, "BIBREF23": {"ref_id": "b23", "title": "COVID-19: combining antiviral and antiinflammatory treatments", "authors": [{"first": "J", "middle": [], "last": "Stebbing", "suffix": ""}, {"first": "A", "middle": [], "last": "Phelan", "suffix": ""}, {"first": "I", "middle": [], "last": "Griffin", "suffix": ""}], "year": 2020, "venue": "Lancet Infect Dis", "volume": "", "issn": "", "pages": "30132--30140", "other_ids": {"DOI": ["10.1016/S1473-3099(20"]}}, "BIBREF24": {"ref_id": "b24", "title": "Non-steroidal anti-inflammatory drugs and covid-19", "authors": [{"first": "P", "middle": [], "last": "Little", "suffix": ""}], "year": 2020, "venue": "BMJ", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1136/bmj.m1185"]}}, "BIBREF25": {"ref_id": "b25", "title": "The antiviral compound remdesivir potently inhibits RNAdependent RNA polymerase from Middle East respiratory syndrome coronavirus", "authors": [{"first": "C", "middle": ["J"], "last": "Gordon", "suffix": ""}, {"first": "E", "middle": ["P"], "last": "Tchesnokov", "suffix": ""}, {"first": "J", "middle": ["Y"], "last": "Feng", "suffix": ""}, {"first": "D", "middle": ["P"], "last": "Porter", "suffix": ""}, {"first": "M", "middle": [], "last": "G\u00f6tte", "suffix": ""}], "year": 2020, "venue": "J Biol Chem", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1074/jbc.AC120.013056"]}}, "BIBREF26": {"ref_id": "b26", "title": "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, This article is protected by copyright. All rights reserved", "authors": [{"first": "X", "middle": [], "last": "Yang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Yu", "suffix": ""}, {"first": "J", "middle": [], "last": "Xu", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1093/qjmed/hcaa089"]}}, "BIBREF27": {"ref_id": "b27", "title": "Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19", "authors": [{"first": "R", "middle": [], "last": "Qu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Ling", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "", "middle": [], "last": "Hui Zhi", "suffix": ""}], "year": 2020, "venue": "J Med Virol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1002/jmv.25767"]}}, "BIBREF28": {"ref_id": "b28", "title": "Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study", "authors": [{"first": "Y", "middle": [], "last": "Deng", "suffix": ""}, {"first": "W", "middle": [], "last": "Liu", "suffix": ""}, {"first": "K", "middle": [], "last": "Liu", "suffix": ""}], "year": null, "venue": "Chin Med J (Engl", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1097/CM9.0000000000000824"]}}, "BIBREF29": {"ref_id": "b29", "title": "Clinical features and treatment of COVID-19 patients in northeast Chongqing", "authors": [{"first": "S", "middle": [], "last": "Wan", "suffix": ""}, {"first": "Y", "middle": [], "last": "Xiang", "suffix": ""}, {"first": "W", "middle": [], "last": "Fang", "suffix": ""}], "year": 2020, "venue": "J Med Virol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1002/jmv.25783"]}}, "BIBREF30": {"ref_id": "b30", "title": "Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms", "authors": [{"first": "X", "middle": [], "last": "Jin", "suffix": ""}, {"first": "J", "middle": ["S"], "last": "Lian", "suffix": ""}, {"first": "J", "middle": ["H"], "last": "Hu", "suffix": ""}], "year": 2020, "venue": "Gut", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1136/gutjnl-2020-320926"]}}, "BIBREF31": {"ref_id": "b31", "title": "Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study", "authors": [{"first": "L", "middle": [], "last": "Pan", "suffix": ""}, {"first": "M", "middle": [], "last": "Mu", "suffix": ""}, {"first": "P", "middle": [], "last": "Yang", "suffix": ""}], "year": 2020, "venue": "Am J Gastroenterol", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.14309/ajg.0000000000000620"]}}, "BIBREF32": {"ref_id": "b32", "title": "The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease", "authors": [{"first": "B", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "J", "middle": [], "last": "She", "suffix": ""}, {"first": "Y", "middle": [], "last": "Wang", "suffix": ""}, {"first": "X", "middle": [], "last": "Ma", "suffix": ""}], "year": 2020, "venue": "J Infect", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1016/j.jinf.2020.03.021"]}}, "BIBREF33": {"ref_id": "b33", "title": "Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease", "authors": [{"first": "J", "middle": [], "last": "Li", "suffix": ""}, {"first": "J", "middle": ["G"], "last": "Fan", "suffix": ""}], "year": 2020, "venue": "J Clin Transl Hepatol", "volume": "8", "issn": "1", "pages": "13--17", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "mild cases of COVID-19 disease with patients that do not require extraordinary measures to manage the diseases and severe cases of COVID-19 infection who developed COVID-related complications such as acute respiratory distress syndrome (ARDS) and respiratory failure, or expired. Exclusion criteria were as follows: (a) duplicate data (b) case reports, series, abstract-only articles, conference article and comment, editorials and expert opinions (c) studies with insufficient outcome data, and (d) preprints (articles in the peer-review stage).", "latex": null, "type": "figure"}, "FIGREF1": {"text": "MY, ASA, RE: study design; MY, ASA, MO, GZ, AE, AS: study identification and data extraction; MH, RE, EAT: statistical analysis; MH, RE, EAT, MSF: data interpretation; MY, ASA, RE, MO, GZ, AF, EAT, MSF: original draft preparation. All authors revised and approved the final version of the manuscript. Abbreviations ACE2: angiotensin-converting enzyme 2; AKI: acute kidney injury, ALT: alanine aminotransferase, ARDS: acute respiratory distress syndrome; AST: Aspartate aminotransferase, COVID-19: Coronavirus Disease 2019; PT: prothrombin time; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; SMD: the standardized mean difference; TSA: Trial sequential analysis. Pierce, C.A., Software Review: Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2006). Comprehensive Meta-Analysis (Version 2.2.027) [Computer software]. Englewood, NJ: Biostat. Organizational Research Methods, 2008. 11(1): p. 188-191. 20. Elshazli RM, Toraih EA, Elgaml A, Kandil E, Fawzy MS. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies. Gene. 2020 Jan 27:144391. 21. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020. doi:10.1111/liv.14435 12. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. Lancet Infect Dis. 2013. doi:10.1016/S1473-3099(13)70204-4 23. Al-Hameed F, Wahla AS, Siddiqui S, et al. Characteristics and outcomes of middle east respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia. J Intensive Care Med. 2014. doi:10.1177/0885066615579858 24. Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia. Int J Infect Dis. 2014. This article is protected by copyright. All rights reserved. Fan Z, Chen L, Li J, et al. Clinical Features of COVID-19-Related Liver Damage. SSRN Electron J. 2020. doi:10.2139/ssrn.3546077 34. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA -J Am Med Assoc. 2020. doi:10.1001/jama.2020.1585 35. Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020. doi:10.1097/CM9.0000000000000775 36. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. doi:10.1007/s00134-020-05991-x 37. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.", "latex": null, "type": "figure"}, "FIGREF2": {"text": "The workflow of the selection process.FIGURE 2 Trial sequential analysis for mortality.", "latex": null, "type": "figure"}, "TABREF0": {"text": "summarize pairwise comparison, heterogeneity analysis, and publication bias of the meta-analysis. Patients who had severe presentations of COVID disease had", "latex": null, "type": "table"}, "TABREF1": {"text": "The analysis showed that patients with hypertension (OR= 2.37, 95%CI=1.86-3.01, p <0.001), chronic kidney disease (OR=7.28, 95%CI =3.26-16.26, p <0. 001), and diabetes (OR= 2.72, 95%CI =2.06-3.61, p <0.001) were nearly two-folds more risk to develop severe presentation of COVID-19. Patients with underlying cardiovascular disease or cerebrovascular disease were five-times more liable to develop severe", "latex": null, "type": "table"}, "TABREF2": {"text": "Our analysis confirmed that patients with severe COVID-19 disease had higher odds of developing acute respiratory distress syndrome (OR=18.84, 95%CI=5.39-65.87, p <0.0001) and sepsis (OR=21.19, 95%CI=4.21-106.7, p <0.001). Similarly, acute liver injury (OR=1.93, 95%CI=1.12-3.34, p = 0.001) and acute kidney injury (OR=7.2, 95%CI=1.38-37.74, p < 0.001) were more prevalent among patient with severe This article is protected by copyright. All rights reserved. disease. Moreover, our analysis revealed that mortality was more likely to occur among patients with severe COVID-19 patients (OR=55.22, 95%CI=12.62-241.66, p <0.001)] (", "latex": null, "type": "table"}, "TABREF4": {"text": "Characteristics of the included studies Ref. reference number, Retro: retrospective. Summarizing results of pooled estimates of liver function tests and clinical parameters of chronic liver patients", "latex": null, "type": "table"}}, "back_matter": []}